PT786518E - Vacina contra streptococus equi - Google Patents

Vacina contra streptococus equi

Info

Publication number
PT786518E
PT786518E PT97200194T PT97200194T PT786518E PT 786518 E PT786518 E PT 786518E PT 97200194 T PT97200194 T PT 97200194T PT 97200194 T PT97200194 T PT 97200194T PT 786518 E PT786518 E PT 786518E
Authority
PT
Portugal
Prior art keywords
equi
streptococus
vaccine against
vaccine
preparation
Prior art date
Application number
PT97200194T
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Orla Mary Hartford
Timothy James Foster
Original Assignee
Trinity College Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT786518(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Trinity College Dublin filed Critical Trinity College Dublin
Publication of PT786518E publication Critical patent/PT786518E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT97200194T 1996-01-25 1997-01-24 Vacina contra streptococus equi PT786518E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200171 1996-01-25

Publications (1)

Publication Number Publication Date
PT786518E true PT786518E (pt) 2002-10-31

Family

ID=8223610

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97200194T PT786518E (pt) 1996-01-25 1997-01-24 Vacina contra streptococus equi

Country Status (16)

Country Link
US (1) US5895654A (pt)
EP (1) EP0786518B1 (pt)
JP (1) JP3911058B2 (pt)
AT (1) ATE219511T1 (pt)
AU (1) AU703942B2 (pt)
BR (1) BRPI9700768B8 (pt)
CA (1) CA2195935C (pt)
CZ (1) CZ289530B6 (pt)
DE (1) DE69713408T2 (pt)
DK (1) DK0786518T3 (pt)
ES (1) ES2179261T3 (pt)
NZ (1) NZ314091A (pt)
PL (1) PL187163B1 (pt)
PT (1) PT786518E (pt)
RU (1) RU2194752C2 (pt)
ZA (1) ZA97452B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682745B1 (en) 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
US20080050367A1 (en) * 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
AU742970C (en) * 1997-12-03 2003-03-20 Janssen Alzheimer Immunotherapy Method of suppressing beta-amyloid-related changes in Alzheimer's disease
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
ES2214217T3 (es) * 1999-01-26 2004-09-16 Akzo Nobel N.V. Utilizacion de bacterias vivas atenuadas para la preparacion de una vacuna de administracion por la submucosa.
US6541458B1 (en) 1999-07-16 2003-04-01 Merial Feline calicivirus genes and vaccines in particular recombinant vaccines
FR2796397B1 (fr) * 1999-07-16 2006-09-01 Merial Sas Genes de calicivirus felin et vaccins notamment vaccins recombines
US20020082288A1 (en) * 1999-09-16 2002-06-27 Gerald Horn Ophthalmic formulations comprising an imidazoline
US6730065B1 (en) * 2000-09-15 2004-05-04 Ocularis Pharma, Inc. Night vision composition
US8889112B2 (en) * 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US6420407B1 (en) 1999-09-16 2002-07-16 Gerald Horn Ophthalmic formulation which modulates dilation
US20060211753A1 (en) * 2000-11-03 2006-09-21 Ocularis Pharma, Inc. Method and composition which reduces stimulation of muscles which dilate the eye
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
JP2008523815A (ja) 2004-12-15 2008-07-10 エラン ファーマ インターナショナル リミテッド 認知の改善における使用のためのヒト化アミロイドβ抗体
US8784810B2 (en) * 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
ES2498040T3 (es) * 2007-07-27 2014-09-24 Janssen Alzheimer Immunotherapy Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
JO3076B1 (ar) * 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
GB0801326D0 (en) 2008-01-24 2008-03-05 Animal Health Trust Vaccines
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
GB201209014D0 (en) * 2012-05-22 2012-07-04 Moredun Res Inst Vaccine
ES2835398T3 (es) 2013-02-01 2021-06-22 Ocuphire Pharma Inc Métodos y composiciones para la administración oftálmica diaria de fentolamina para mejorar el rendimiento visual
DK2950648T3 (da) 2013-02-01 2019-12-02 Ocuphire Pharma Inc Vandige oftalmiske opløsninger af phentolamin og medicinske anvendelser deraf
WO2015057777A1 (en) 2013-10-17 2015-04-23 Zoetis Llc Methods and compositions for treatment of s. equi infection
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
GB2564481B (en) * 2017-07-14 2019-10-23 4D Pharma Leon S L U Process
US12161629B2 (en) 2018-10-15 2024-12-10 Opus Genetics, Inc. Methods and compositions for treatment of glaucoma and related conditions
BR112021007725A2 (pt) 2018-10-26 2021-07-27 Ocuphire Pharma, Inc. métodos e composições para tratamento de presbiopia, midríase e outros distúrbios oculares
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4582798A (en) * 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine
AR241545A1 (es) * 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US4788059A (en) * 1985-07-15 1988-11-29 Coopers Animal Health, Inc. Equine strangles vaccine and the method of preparing and using the same
US5468485A (en) * 1987-06-04 1995-11-21 Washington University Avirulent microbes and uses therefor
US5294441A (en) * 1987-06-04 1994-03-15 Washington University Avirulent microbes and uses therefor: salmonella typhi
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
EP0381706B1 (en) * 1987-10-07 1995-04-26 Washington University A method of maintaining a desired recombinant gene in a genetic population of cells
EP0626452B1 (en) * 1993-05-17 1999-08-11 Akzo Nobel N.V. Vaccine against Streptococcus suis infection
ES2132330T3 (es) * 1993-12-20 1999-08-16 Akzo Nobel Nv Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.

Also Published As

Publication number Publication date
BRPI9700768B1 (pt) 2008-11-04
CA2195935A1 (en) 1997-07-26
ATE219511T1 (de) 2002-07-15
DE69713408D1 (de) 2002-07-25
DK0786518T3 (da) 2002-09-16
EP0786518B1 (en) 2002-06-19
EP0786518A1 (en) 1997-07-30
US5895654A (en) 1999-04-20
PL187163B1 (pl) 2004-05-31
NZ314091A (en) 1998-06-26
DE69713408T2 (de) 2002-11-21
BR9700768A (pt) 1998-11-03
ZA97452B (en) 1997-08-15
CZ21497A3 (cs) 1998-03-18
JPH09215492A (ja) 1997-08-19
JP3911058B2 (ja) 2007-05-09
CA2195935C (en) 2006-06-27
CZ289530B6 (cs) 2002-02-13
ES2179261T3 (es) 2003-01-16
PL318095A1 (en) 1997-08-04
BRPI9700768B8 (pt) 2016-11-16
AU703942B2 (en) 1999-04-01
AU1234697A (en) 1997-08-07
RU2194752C2 (ru) 2002-12-20

Similar Documents

Publication Publication Date Title
PT786518E (pt) Vacina contra streptococus equi
AU8483391A (en) Improved oligosaccharide conjugate vaccines
MY125202A (en) Vaccine
MY113428A (en) Hepatitis b vaccine
BG100960A (en) Dosage forms for controlled release of azitromycin
ATE242319T1 (de) Deletionsmutanten als impfstoffe gegen cholera
WO1998056901A3 (en) Live attenuated vaccines
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
NZ287385A (en) Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
BR0009663A (pt) Composições de vacinas antibacterianas
AU1801195A (en) Antigenic preparation for treatment or prevention of helicobacter infection
AU2002217043A1 (en) Salmonella vaccine
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
BR0116788A (pt) Cepa de lactobacillus que produz levano e seu uso em produtos alimentìcios para seres humanos ou para animais de estimação
NZ335050A (en) Helicobacter pylori live vaccine
PT858501E (pt) Fermentos lactios e a sua utilizacao para a obtencao de produtos hipocolesterolemiantes
ZA9710205B (en) Bacterial antigens and vaccine compositions II.
Hartford et al. Streptococcus equi vaccine
AU3550599A (en) Enterotoxin-deficient bacillus
BG100055A (en) Kalfinella sacoidosis sp. novo strain for making preparations for allergological, serological and immunological diagnosis of sarcoidosis, crohn's disease and mediterranean fever
RU94022337A (ru) Штамм бактерий proteus mirabilis - продуцент термолабильного энтеротоксина
AP1679A (en) Outer surface proteins, their genes, and their use.
WO2000072803A3 (en) Streptococcus pneumoniae vaccine strain and uses thereof
UA32269A (uk) Спосіб лікування пневмоній у дітей